What is Molecular Instruments?
Molecular Instruments, Inc. is dedicated to pioneering advanced imaging technologies crucial for in situ hybridization (ISH) and immunofluorescence (IF) applications. Their product suite, including the HCR RNA-FISH/IF system, empowers researchers to perform simultaneous, quantitative, and high-resolution imaging of RNA and proteins within intact tissues. The company's innovative HCR HiFi Encoder simplifies multiplex immunofluorescence by leveraging established primary antibodies with an efficient protocol. Furthermore, Molecular Instruments offers enzyme-free signal amplification solutions, such as HCR Gold RNA-FISH, designed for high sensitivity and adaptability across diverse research targets. These offerings are specifically tailored for molecular biology and tissue analysis laboratories seeking enhanced precision and insight.
How much funding has Molecular Instruments raised?
Molecular Instruments has raised a total of $127K across 1 funding round:
Debt
$127K
Debt (2021): $127K with participation from PPP
What's next for Molecular Instruments?
With the recent {{recentFundingContext}} of $127K and a substantial overall capital base of $127K, Molecular Instruments is strategically positioned for its next phase of growth. This large-scale, late-stage funding indicates a strong market validation and provides the necessary resources for scaling operations, expanding market reach, and potentially accelerating research and development efforts. The company is likely to focus on enhancing its product commercialization, forging strategic partnerships, and further solidifying its position as a leader in high-resolution molecular imaging solutions for the global research community.
See full Molecular Instruments company page
